Skip to main content

Inflammatory Bowel Diseases

  • Chapter
  • First Online:
Colitis

Abstract

Inflammatory bowel disease (IBD) is a group of chronic idiopathic inflammatory conditions. The two major types are ulcerative colitis (UC) which affects the colon and Crohn’s disease (CD) which can involve the whole gastrointestinal tract but is most common in the terminal ileum and colon. There is a genetic predisposition for IBD, and patients with this condition are more prone to the development of malignancy. Further types to be considered are indeterminate colitis (IC) and inflammatory bowel disease unclassified (IBDU). These are essentially “temporary diagnoses” when the difference between UC and CD cannot be established definitely at the time of presentation. IC should be used when examination of surgical samples is available together with clinical, serological, and imaging data, while IBDU is used for patients from whom only endoscopic biopsies are available. CD and UC must be considered in the differential diagnosis of clinically acute colitis because of differences in treatment strategies between infections and IBD. The differential diagnosis is particularly important when the complaints are persisting. Histology plays a key role in the diagnosis. Major diagnostic features of UC are architectural distortion and basal plasmacytosis. It has been suggested that “microscopic colitis” would also be member of the chronic inflammatory bowel diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pera A, Bellardo P, Caldera A, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of endoscopic score. Gastroenterology. 1987;92:181–5.

    Article  PubMed  CAS  Google Scholar 

  2. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26:31–41.

    Article  PubMed  Google Scholar 

  3. Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–6.

    Article  PubMed  Google Scholar 

  4. Joo M, Abreu-E-Lima P, Farraye F, et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009;33:854–62.

    Article  PubMed  Google Scholar 

  5. Jörgensen KK, Grzyb K, Lundin KEA, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18:536–45.

    Article  PubMed  Google Scholar 

  6. Wright R, Truelove SR. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis. 1966;11:847–57.

    Article  PubMed  CAS  Google Scholar 

  7. Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174–8.

    Article  PubMed  CAS  Google Scholar 

  8. Hefti MM, Chessin DB, Harpaz NH, et al. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum. 2009;52:193–7.

    Article  PubMed  Google Scholar 

  9. Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology. 1987;92:318–28.

    Article  PubMed  CAS  Google Scholar 

  10. Therkildsen MH, Jensen BN, Stubbe P, Rasmussen TS. The final outcome of patients presenting with their first episode of acute diarrhea and an inflamed mucosa with preserved crypt architecture. A clinicopathologic study. Scand J Gastroenterol. 1989;24:158–64.

    Article  PubMed  CAS  Google Scholar 

  11. Odze R, Antonioli D, Peppercorn M, et al. Effect of topical 5-amino-salicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol. 1993;17:869–75.

    Article  PubMed  CAS  Google Scholar 

  12. Rubio CA, Johansson C, Uribe A, Kock J. A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission. Scand J Gastroenterol. 1982;17:1077–81.

    PubMed  CAS  Google Scholar 

  13. Geboes K, El-Deeb G, El-Haddad S, Desmet VJ. Challenges in ulcerative colitis; the pathologist’s point of view. Acta Endosc. 1994;24:313–26.

    Article  Google Scholar 

  14. Schumacher G, Kollberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol. 1994;29:318–32.

    Article  PubMed  CAS  Google Scholar 

  15. Surawicz C. What’s the best way to differentiate infectious colitis (acute self-limited colitis) from IBD? Inflamm Bowel Dis. 2008;14:s157–8.

    Article  PubMed  Google Scholar 

  16. Sachar DB, Andrews H, Farmer RG, et al. Proposed classification of patient subgroups in Crohn’s disease. Working team report 4. Gastroenterol Int. 1992;3:141–54.

    Google Scholar 

  17. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup. Gastroenterology. 1996;110:1810–9.

    Article  PubMed  CAS  Google Scholar 

  18. Geboes K, Ectors N. Diagnosis of ulcerative colitis in endoscopic biopsies. Hepato-Gastroenterology. 1989;36:188–92.

    PubMed  CAS  Google Scholar 

  19. Forbes E, et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol. 2004;172:5664–75.

    Article  PubMed  CAS  Google Scholar 

  20. Mir A, et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol. 2002;97:1452–7.

    Article  PubMed  CAS  Google Scholar 

  21. Heatley RV, James PD. Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis? Gut. 1979;20:787–91.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Bischoff SC, Mayer J, Nguyen QT, et al. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol. 1999;94:3521–9.

    Article  PubMed  CAS  Google Scholar 

  23. Raab Y, Fredens K, Gerdin B, Hällgren R. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci. 1998;43:1061–70.

    Article  PubMed  CAS  Google Scholar 

  24. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13–20.

    Article  PubMed  CAS  Google Scholar 

  25. Bessissow T, Lemmens B, Ferrante M, et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol. 2012;107:1684–92.

    Article  PubMed  Google Scholar 

  26. Keren DF, Appelman HD, Dobbins WO 3rd, et al. Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease. Hum Pathol. 1984;15:757–63.

    Article  PubMed  CAS  Google Scholar 

  27. Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J. 1956;1:1315–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Bressenot A, Geboes K, Vignaud JM, et al. Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1745–52.

    Article  PubMed  Google Scholar 

  29. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101:2857–65.

    Article  PubMed  CAS  Google Scholar 

  30. Ayre K, Warren BF, Jeffery K, Travis SP. The role of CMV in steroid-resistant ulcerative colitis: a systematic review. J Crohns Colitis. 2009;3:141–8.

    Article  PubMed  Google Scholar 

  31. Kuwabara A, Okamoto H, Suda T, et al. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007;42:823–9.

    Article  PubMed  Google Scholar 

  32. Markowitz J, Kahn E, Grancher K, et al. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol. 1993;88:2034–7.

    PubMed  CAS  Google Scholar 

  33. Robert ME, Tang L, Hao M, Reyes-Mugica M. Patterns of inflammation in mucosal biopsies of ulcerative colitis. Perceived differences in pediatric populations are limited to children younger than 10 years. Am J Surg Pathol. 2004;28:183–9.

    Article  PubMed  CAS  Google Scholar 

  34. Washington K, Greenson JK, Montgomery E, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol. 2002;26:1441–9.

    Article  PubMed  Google Scholar 

  35. Geboes K, Van Eyken P. My approach to indeterminate colitis: the role of the pathologist. J Clin Pathol. 2009;62:201–5.

    Article  PubMed  CAS  Google Scholar 

  36. Villanacci V, Antonelli E, Geboes K, et al. Histological healing in inflammatory bowel disease: a still unfulfilled promise. World J Gastroenterol. 2013;19:968–78.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mosli MH, Feagan B, Sandborn WJ, et al. Histologic evaluation of disease activity in ulcerative colitis: a systematic review of histological disease activity indices. Inflamm Bowel Dis. 2014;20:564–75.

    Article  PubMed  Google Scholar 

  38. Dourmashkin RR, Davies H, Wells C, Shah D, et al. Epithelial patchy necrosis in Crohn’s disease. Hum Pathol. 1983;14:643–8.

    Article  CAS  PubMed  Google Scholar 

  39. Dvorak A, Connell AB, Dickersin GR. Crohn’s disease: a scanning electron microscopic study. Hum Pathol. 1979;10:165–77.

    Article  CAS  PubMed  Google Scholar 

  40. Cuvelier CA, Quatacker J, Mielants H, et al. M cells are damaged and increased in number in inflamed human ileal mucosa. Eur J Morphol. 1993;31:87–91.

    PubMed  CAS  Google Scholar 

  41. Fujimura Y, Hosobe M, Kihara T. Ultrastructural study of M cells from colonic lymphoid nodules obtained by colonoscopic biopsy. Dig Dis Sci. 1992;37:1089–98.

    Article  PubMed  CAS  Google Scholar 

  42. Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn’s disease. Hepato-Gastroenterology. 1990;37:18–31.

    PubMed  CAS  Google Scholar 

  43. Sankey EA, Dhillon AP, Anthony A, et al. Early mucosal changes in Crohn’s disease. Gut. 1993;34:375–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Sanders DS. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn’s disease. J Clin Pathol. 2005;58:568–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Maunoury V, Mordon S, Geboes K, et al. Early vascular changes in Crohn’s disease: an endoscopic fluorescence study. Endoscopy. 2000;32:700–5.

    Article  PubMed  CAS  Google Scholar 

  46. Heresbach D, Heresbach-Le Berre N, Ramée MP, et al. Fréquence et valeur pronostique du granulome épithélioïde au cours des maladies inflammatoires chroniques de l’intestin. Gastroenterol Clin Biol. 1999;23:1376–87.

    PubMed  CAS  Google Scholar 

  47. Geboes K, Vantrappen G. The value of colonoscopy in the diagnosis of Crohn’s disease. Gastrointest Endosc. 1975;22:18–23.

    Article  PubMed  CAS  Google Scholar 

  48. Jouret A, Mainguet P. Diagnostic value of systematic endoscopic biopsies in ileocolonic Crohn’s disease. Acta Gastroenterol Belg. 1993;56:C71.

    Google Scholar 

  49. Chambers TJ, Morson BC. The granuloma in Crohn’s disease. Gut. 1979;20:269–74.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Baert F, Hart J, Blackstone MO. A case of diclofenac-induced colitis with focal granulomatous change. Am J Gastroenterol. 1995;90:1871–3.

    PubMed  CAS  Google Scholar 

  51. Mathew RC, Weinstock JV. Granuloma formation. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams & Wilkins; 1994. p. 151–9.

    Google Scholar 

  52. Sanders DSA. The differential diagnosis of Crohn’s disease and ulcerative colitis. Baillieres Clin Gastroenterol. 1998;12:19–33.

    Article  PubMed  CAS  Google Scholar 

  53. Chiba M. Crohn’s disease associated with diffuse lymphoid hyperplasia of the large intestine: a possible role of the lymph follicle in HLA-DR expression on epithelium. Intern Med. 1992;31:1271–6.

    Article  PubMed  CAS  Google Scholar 

  54. Rotterdam H, Korelitz BI, Sommers SC. Microgranulomas in grossly normal rectal mucosa in Crohn’s disease. Am J Clin Pathol. 1977;67:550–4.

    Article  PubMed  CAS  Google Scholar 

  55. Surawicz CM, Rubin CE. Epithelioid granuloma and related histologic features which may differentiate Crohn’s disease from ulcerative colitis in rectal biopsies. In: Rachmilewitz D, editor. Inflammatory bowel diseases. The Hague: Martinus Nijhoff; 1982. p. 19–26.

    Chapter  Google Scholar 

  56. Sandmeier D, Bouzourene H. Microscopic colitis with giant cells: a rare new histopathologic subtype? Int J Surg Pathol. 2004;12:45–8.

    Article  PubMed  CAS  Google Scholar 

  57. Kayser K, Probst F, Gabius HJ, et al. Are there characteristic alterations of lung tissue associated with Crohn’s disease. Pathol Res Pract. 1990;186:485–90.

    Article  PubMed  CAS  Google Scholar 

  58. Desmet VJ, Geboes K. Liver lesions in inflammatory bowel disorders. J Pathol. 1987;151:247–55.

    Article  PubMed  CAS  Google Scholar 

  59. Van Patter WN, Bargen JA, Dockerty MB, et al. Regional enteritis. Gastroenterology. 1954;26:347–75.

    Google Scholar 

  60. Kelly JK, Sutherland LR. The chronological sequence in the pathology of Crohn’s disease. J Clin Gastroenterol. 1988;10:28–33.

    Article  PubMed  CAS  Google Scholar 

  61. Roberts PL, Schoetz DJ, Pricolo R, et al. Clinical course of Crohn’s disease in older patients. A retrospective study. Dis Colon Rectum. 1990;33:458–62.

    Article  PubMed  CAS  Google Scholar 

  62. Markowitz J, Kahn E, Daum F. Prognostic significance of epithelioid granulomas found in rectosigmoid biopsies at the initial presentation of pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr. 1989;9:182–6.

    Article  PubMed  CAS  Google Scholar 

  63. Pötzi R, Walgram M, Lochs H, et al. Diagnostic significance of endoscopic biopsy in Crohn’s disease. Endoscopy. 1989;21:60–2.

    Article  PubMed  Google Scholar 

  64. Domizio P. Pathology of chronic inflammatory bowel disease in children. Baillieres Clin Gastroenterol. 1994;8:35–63.

    Article  PubMed  CAS  Google Scholar 

  65. Theodossi A, Spiegelhalter DJ, Jass J, et al. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut. 1994;35:961–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. Surawicz CM. Serial sectioning of a portion of a rectal biopsy detects more focal abnormalities. A prospective study of patients with inflammatory bowel disease. Dig Dis Sci. 1982;27:434–6.

    Article  PubMed  CAS  Google Scholar 

  67. Smedh K, Olaison G, Franzén L, et al. Endoscopic and external bowel changes and histopathology in patients with Crohn’s disease. Br J Surg. 1995;82:191–4.

    Article  PubMed  CAS  Google Scholar 

  68. Wolfson DM, Sachar DB, Cohen A, et al. Granulomas do not affect postoperative recurrence rates in Crohn’s disease. Gastroenterology. 1982;83:405–9.

    PubMed  CAS  Google Scholar 

  69. Glass RE, Baker WNW. The role of the granuloma in recurrent Crohn’s disease. Gut. 1976;17:75–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Heresbach D, Alexandre JL, Branger B, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn’s disease. Gut. 2005;54:215–22.

    Article  PubMed  CAS  Google Scholar 

  71. Pierik M, De Hertogh G, Vermeire S, et al. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn’s disease. Gut. 2005;54:223–7.

    Article  PubMed  CAS  Google Scholar 

  72. Shaoul R, Karban A, Weiss B, et al. NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn’s disease. Inflamm Bowel Dis. 2004;10:709–14.

    Article  PubMed  Google Scholar 

  73. Heresbach D, Gicquel-Douabin V, Birebent B, et al. NOD2/CARD15 gene polymorphism in Crohn’s disease: a genotype phenotype analysis. Eur J Gastroenterol Hepatol. 2004;16:55–62.

    Article  PubMed  CAS  Google Scholar 

  74. Lennard-Jones JE. Crohn’s disease: definition, pathogenesis and aetiology. In: Wright R, editor. Recent advances in gastrointestinal pathology. London: WB Saunders; 1980. p. 173–89.

    Google Scholar 

  75. Hamilton SR. Diagnosis and comparison of ulcerative colitis and Crohn’s disease involving the colon. In: Norris HT, editor. Pathology of the colon, small intestine and anus. New York: Churchill Livingstone; 1983. p. 1.

    Google Scholar 

  76. Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol. 1997;50:93–10511.

    Article  PubMed  CAS  Google Scholar 

  77. Jenkins D, Goodall A, Drew K, et al. What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol. 1988;41:72–9.

    Article  PubMed  CAS  Google Scholar 

  78. Surawicz CM, Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology. 1984;86:104–13.

    PubMed  CAS  Google Scholar 

  79. Schmitz-Moormann P, Himmelmann GW. Does quantitative histology of rectal biopsy improve the differential diagnosis of Crohn’s disease and ulcerative colitis in adults? Pathol Res Pract. 1988;183:481–8.

    Article  PubMed  CAS  Google Scholar 

  80. Seldenrijk CA, Morson BC, Meuwissen SGM, et al. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut. 1991;32:1514–20.

    Article  PubMed  CAS  Google Scholar 

  81. Shepherd NA. Granulomas in the diagnosis of intestinal Crohn’s disease: a myth exploded. Histopathology. 2002;41:166–8.

    Article  PubMed  CAS  Google Scholar 

  82. Tanaka M, Riddell RH, Saito H, et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn’s disease from ulcerative colitis. Scand J Gastroenterol. 1999;34:55–67.

    Article  PubMed  CAS  Google Scholar 

  83. Tanaka M, Saito H, Fukuda S, et al. Simple mucosal biopsy criteria differentiating among Crohn’s disease, ulcerative colitis and other forms of colitis: measurement of validity. Scand J Gastroenterol. 2000;35:281–6.

    Article  PubMed  CAS  Google Scholar 

  84. Schmitz-Moormann P, Schäg M. Histology of the lower intestinal tract in Crohn’s disease of children and adolescents. Pathol Res Pract. 1990;186:479–84.

    Article  PubMed  CAS  Google Scholar 

  85. Geboes K, Ectors N, D’Haens G, et al. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of IBD. Am J Gastroenterol. 1998;93:201–6.

    Article  PubMed  CAS  Google Scholar 

  86. Cuvelier C, Demetter P, Mielants H, et al. Interpretation of ileal biopsies: morphological features in normal and diseased mucosa. Histopathology. 2001;38:1–12.

    Article  PubMed  CAS  Google Scholar 

  87. Courville EL, Siegerl CA, Vay T, et al. Isolated asymptomatic ileitis does not progress to overt Crohn disease on long-term follow-up despite features of chronicity in ileal biopsies. Am J Surg Pathol. 2009;33:1341–7.

    Article  PubMed  Google Scholar 

  88. Bentley E, Jenkins D, Campbell F, et al. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol. 2002;55:955–60.

    Article  PubMed  CAS  Google Scholar 

  89. Dejaco C, Osterreicher C, Angelberger S, Puspok A, et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy. 2003;35:1004–8.

    Article  PubMed  CAS  Google Scholar 

  90. Escher JC, Ten Kate F, Lichtenbelt SK, et al. Value of rectosigmoidoscopy with biopsies for diagnosis of inflammatory bowel disease in children. Inflamm Bowel Dis. 2002;8:16–22.

    Article  PubMed  Google Scholar 

  91. Gomes P, Du Boulay C, Smith CL, et al. Relationship between disease activity and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986;27:92–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. D’Haens G, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: a European multicenter trial. Gastroenterology. 1999;116:1029–34.

    Article  PubMed  Google Scholar 

  93. Schmitz-Moorman P, Brandes JW, Jesdinsky H, et al. Relationships between drug regime and histology of rectal mucosa in CD. Pathol Res Pract. 1988;183:30–4.

    Article  Google Scholar 

  94. Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827–51.

    Article  PubMed  CAS  Google Scholar 

  95. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease - “colitis indeterminate”. J Clin Pathol. 1978;31:567–77.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Kent TH, Ammon RK, DenBesten L. Differentiation of ulcerative colitis and regional enteritis. Arch Pathol. 1970;89:20–9.

    PubMed  CAS  Google Scholar 

  97. Branco BC, Harpaz N, Sachar D, et al. Colorectal carcinoma in indeterminate colitis. Inflamm Bowel Dis. 2009;15:1076–81.

    Article  PubMed  Google Scholar 

  98. Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept – what’s in a name? Inflamm Bowel Dis. 2008;14:860–7.

    Article  Google Scholar 

  99. Silverberg M, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):1A–32A.

    Article  Google Scholar 

  100. Sonnenberg A, Melton RD, Genta RM. Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:39–44.

    Article  PubMed  Google Scholar 

  101. Parente F, Cucino C, Bollani S, et al. Focal gastric inflammatory infiltrates in inflammatory bowel diseases. Prevalence, immunohistochemical characteristics and diagnostic role. Am J Gastroenterol. 2000;95:705–11.

    Article  PubMed  CAS  Google Scholar 

  102. Castellaneta SP, Afzzal NA, Greenberg M, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2004;39:257–61.

    Article  PubMed  CAS  Google Scholar 

  103. Lopes S, Figueiredo P, Portela F, et al. Capsule endoscopy in inflammatory bowel disease type unclassified and indeterminate colitis, serologically negative. Inflamm Bowel Dis. 2010;16:1663–8.

    Article  PubMed  Google Scholar 

  104. Auvin S, Molinié F, Gower-Rousseau C, et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr. 2005;41:49–55.

    Article  PubMed  Google Scholar 

  105. Bentsen BS, Moum B, Ekbom A. Incidence of inflammatory bowel disease in children in southeastern Norway. A prospective population-based study 1990-94. Scand J Gastroenterol. 2002;37:540–5.

    Article  PubMed  CAS  Google Scholar 

  106. Hildebrand H, Fredrikson B, Holmquist L, et al. Chronic inflammatory bowel disease in children and adolescents in Sweden. J Pediatr Gastroenterol Nutr. 1991;13:293–7.

    Article  PubMed  CAS  Google Scholar 

  107. IBD Working group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.

    Article  Google Scholar 

  108. Yantiss RK, Farraye FA, O’Brien MJ, et al. Prognostic significance or superficial fissuring ulceration in patients with severe “indeterminate” colitis. Am J Surg Pathol. 2006;30:165–70.

    Article  PubMed  Google Scholar 

  109. Lee KS, Medline A, Shockey Q. Indeterminate colitis in the spectrum of inflammatory bowel disease. Arch Pathol Lab Med. 1979;103:173–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Geboes, K., Dewit, O., Moreels, T.G., Faa, G., Jouret-Mourin, A. (2018). Inflammatory Bowel Diseases. In: Jouret-Mourin, A., Faa, G., Geboes, K. (eds) Colitis. Springer, Cham. https://doi.org/10.1007/978-3-319-89503-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-89503-1_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-89502-4

  • Online ISBN: 978-3-319-89503-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics